380 related articles for article (PubMed ID: 33430990)
1. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.
Jiang D; Lei T; Wang Z; Shen C; Cao D; Hou T
J Cheminform; 2020 Mar; 12(1):16. PubMed ID: 33430990
[TBL] [Abstract][Full Text] [Related]
2. ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity.
Lei T; Chen F; Liu H; Sun H; Kang Y; Li D; Li Y; Hou T
Mol Pharm; 2017 Jul; 14(7):2407-2421. PubMed ID: 28595388
[TBL] [Abstract][Full Text] [Related]
3. ADMET Evaluation in Drug Discovery. 18. Reliable Prediction of Chemical-Induced Urinary Tract Toxicity by Boosting Machine Learning Approaches.
Lei T; Sun H; Kang Y; Zhu F; Liu H; Zhou W; Wang Z; Li D; Li Y; Hou T
Mol Pharm; 2017 Nov; 14(11):3935-3953. PubMed ID: 29037046
[TBL] [Abstract][Full Text] [Related]
4. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
Erić S; Kalinić M; Ilić K; Zloh M
SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
[TBL] [Abstract][Full Text] [Related]
5. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
[TBL] [Abstract][Full Text] [Related]
6. Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets.
Wu Z; Zhu M; Kang Y; Leung EL; Lei T; Shen C; Jiang D; Wang Z; Cao D; Hou T
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33313673
[TBL] [Abstract][Full Text] [Related]
7. Ensemble Machine Learning Approaches Based on Molecular Descriptors and Graph Convolutional Networks for Predicting the Efflux Activities of MDR1 and BCRP Transporters.
Adachi A; Yamashita T; Kanaya S; Kosugi Y
AAPS J; 2023 Sep; 25(5):88. PubMed ID: 37700207
[TBL] [Abstract][Full Text] [Related]
8. Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning Approaches.
Belekar V; Lingineni K; Garg P
Comb Chem High Throughput Screen; 2015; 18(5):476-85. PubMed ID: 26004050
[TBL] [Abstract][Full Text] [Related]
9. Predicting Inhibitors for Multidrug Resistance Associated Protein-2 Transporter by Machine Learning Approach.
Kharangarh S; Sandhu H; Tangadpalliwar S; Garg P
Comb Chem High Throughput Screen; 2018; 21(8):557-566. PubMed ID: 30360705
[TBL] [Abstract][Full Text] [Related]
10. In silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2).
Ding YL; Shih YH; Tsai FY; Leong MK
PLoS One; 2014; 9(3):e90689. PubMed ID: 24614353
[TBL] [Abstract][Full Text] [Related]
11. Identification of structural fingerprints for ABCG2 inhibition by using Monte Carlo optimization, Bayesian classification, and structural and physicochemical interpretation (SPCI) analysis.
Ghosh K; Bhardwaj B; Amin SA; Jha T; Gayen S
SAR QSAR Environ Res; 2020 Jun; 31(6):439-455. PubMed ID: 32539470
[TBL] [Abstract][Full Text] [Related]
12. A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method.
Zhong L; Ma CY; Zhang H; Yang LJ; Wan HL; Xie QQ; Li LL; Yang SY
Comput Biol Med; 2011 Nov; 41(11):1006-13. PubMed ID: 21924412
[TBL] [Abstract][Full Text] [Related]
13. DeepStack-DTIs: Predicting Drug-Target Interactions Using LightGBM Feature Selection and Deep-Stacked Ensemble Classifier.
Zhang Y; Jiang Z; Chen C; Wei Q; Gu H; Yu B
Interdiscip Sci; 2022 Jun; 14(2):311-330. PubMed ID: 34731411
[TBL] [Abstract][Full Text] [Related]
14. Classification of FLT3 inhibitors and SAR analysis by machine learning methods.
Zhao Y; Tian Y; Pang X; Li G; Shi S; Yan A
Mol Divers; 2023 May; ():. PubMed ID: 37142889
[TBL] [Abstract][Full Text] [Related]
15. Discovering the Active Ingredients of Medicine and Food Homologous Substances for Inhibiting the Cyclooxygenase-2 Metabolic Pathway by Machine Learning Algorithms.
Tian Y; Zhang Z; Yan A
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836625
[TBL] [Abstract][Full Text] [Related]
16. Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model.
Kosugi Y; Mizuno K; Santos C; Sato S; Hosea N; Zientek M
AAPS J; 2021 May; 23(4):72. PubMed ID: 34008121
[TBL] [Abstract][Full Text] [Related]
17. Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning.
Montanari F; Zdrazil B; Digles D; Ecker GF
J Cheminform; 2016; 8():7. PubMed ID: 26855674
[TBL] [Abstract][Full Text] [Related]
18. Classification models and SAR analysis on thromboxane A
Ji Y; Li R; Tian Y; Chen G; Yan A
SAR QSAR Environ Res; 2022 Jun; 33(6):429-462. PubMed ID: 35678125
[TBL] [Abstract][Full Text] [Related]
19. Predicting drug-target interaction network using deep learning model.
You J; McLeod RD; Hu P
Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
[TBL] [Abstract][Full Text] [Related]
20. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein.
Zhang S; Yang X; Coburn RA; Morris ME
Biochem Pharmacol; 2005 Aug; 70(4):627-39. PubMed ID: 15979586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
